Your Navigation:PCAR > Abstract
Search pcar
检索项:
检索词:
Abstract
Pharmaceutical Care and Research: 2018; 18(1):58-62
DOI: 10.5428/pcar20180115
Typical case analysis of pharmaceutical care of critical patients treated with vancomycin
1. CHEN Ying1(1.Department of Pharmacy,People’s Hospital of Wuhan University,Wuhan 430060,China cheny@whu.edu.cn)
2. SONG JinChun1(1.Department of Pharmacy,People’s Hospital of Wuhan University,Wuhan 430060,China )
3. HE Juan2(2.Department of Pharmacy,Ruijin Hospital Affiliated to School of Medicine,Shanghai Jiaotong University,Shanghai 200025,China hejuanwin@126.com)
ABSTRACT  Objective: To investigate the main problems in pharmaceutical care of critical patients treated with vancomycin.Methods: A typical case was analyzed and summarized through pharmaceutical care and practice in the use of vancomycin.Results: Pharmaceutical care and practice by clinical pharmacists in the care of critical patients could be implemented by the following procedures: the development,adjustment and optimization of initial vancomycin medication profiles,analysis of abnormal fluctuation of serum drug concentration,and the identification and management of adverse drug reactions.In-time communication between pharmacists,physicians and nurses could ensure accurate and effective use of drugs clinically.Conclusion: Pharmaceutical care in the medication of vancomycin included development,adjustment and optimization of medication profiles,monitoring of serum drug concentration and management of adverse drug reactions.
Welcome to PCAR! You are the number 519 reader of this article!
Please cite this article as:
CHEN Ying1,SONG JinChun1,HE Juan2,. Typical case analysis of pharmaceutical care of critical patients treated with vancomycin[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2018; 18(1): 58-62.
References:
1. Anon.Chinese expert consensus on clinical application of vancomycin(2011 ed)[J].Chin J New Drugs Clin Rem,2011,30(8):561-573.In Chinese.
2. SHEN Ping,WEI ZeQing,CHEN YunBo,et al.Mohnarin report of 2011:monitoring of bacterial resistance in intensive care unit[J].Chin J Nosocomiol,2012,22(24):5472-5476.In Chinese with English abstract.
3. XUE Feng,LI Yun,MA XuZhu.Mohnarin report 2010:surveillance of antimicrobial resistance of clinical isolates from non-ICU inpatiens[J].Chin J Nosocomiol,2012,22 (1):28-33.In Chinese with English abstract.
4. Expert Committee of Clinical Application Dosage of Vancomycin.Chinese expert consensus on clinical application dosage of vancomycin[J].Chin J Infect Dis,2012,30(11):641-646.In Chinese.
5. SHAN TiChao,WU DaWei,GUO RuiChen.Study on pharmacokinetics of vancomycin in ICU patients[D].Jinan: Shandong University,2011.In Chinese with English abstract.
6. Truong J,Levkovich B J,Padiqlione A A.Simple approach to improving vancomycin dosing in intensive care:a standardised loading dose results in earlier therapeutic levels[J].Intern Med J,2012,42 (1):23-29.
7. Hong L T,Goolsby T A,Sherman D S,et al.Continuous infusion vs intermittent vancomycin in neurosurgical intensive care unit patients[J].J Crit Care,2015,30:1153e1-1153e6.
8. HAO JingJing,CHEN Han,ZHOU JianXin.Continuous versus intermittent infusion of vancomycin in adult patients:a systematic review and meta-analysis[J].Int J Antimicrob Agent,2016,47:28-35.
9. van Maarseveen E M,Gipmans S,Vasbinder E,et al.Switching from intermittent to continuous infusion of vancomycin in critically ill patients: toward a more robust exposure[J].Ther Drug Monit,2016,38:398-401.
10. Gilbert D N.Hot disease-the Sanford guide of antimicrobial therapy[M].46th ed.Translated by FAN HongWei,et al.Beijing:Peking Union Medical College Press,2017:119.In Chinese.
11. Raverdy V,Ampe E,Hecq J D,et al.Stability and compatibility of vancomycin for administration by continuous infusion[J].J Antimicrob Chemother,2013,68:1179-1182.
12. HANG YongFu,XIE Cheng,GAO Jie.Monitoring points of vancomycin use in intensive care units[J].Chin J New Drugs,2014,23 (15):1833-1836.In Chinese with English abstract.
13. ZHU Man,GUO DaiHong,LIU GuiYang,et al. Analysis on blood concentration monitoring of vancomycin and clinical administration behavior[J].China Pharmacy,2010,21(14):1282-1285.In Chinese with English abstract.
14. TAN HuiXin.Document analysis on adverse drug reactions induced by vancomycin from 2001 to 2013[J].Drugs Clin,2013,28(4):598-601.In Chinese with English abstract.
《药学服务与研究》杂志社 All Rights Reserved 网站备案号:鲁B2-20061008
·地址:上海市杨浦区长海路168号18号楼东三楼 邮政编码:200433
·联系电话(传真):86-21-65519829, 021-31162330
·电子邮件:PharmCR@vip.163.com
·技术支持:中国康网
管理员入口